IP Library Assignment 048322/0411
Patent Assignment
Reel/Frame 048322/0411

Assignment of Assignor's Interest

Recorded: 2019-02-13 Pages: 17
Assignor
PIERIAN HOLDINGS, INC.
Executed: 2018-08-31
Assignee
NESTEC S.A.
55 AVENUE NESTLE, VEVEY, CH-1800, SWITZERLAND
Covered Property (1)
Biomarkers for Determining Sensitivity of Breast Cancer Cells to HER2-Targeted Therapy
Patent: 9,726,669 →
Application: 12/854,144 →
Publication: US 2011/0071042
Related Assignments (8)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 29, 2010
From: KIM, PHILLIP; LIU, XINJUN; KIRKLAND, RICHARD; LEE, TANI
To: PROMETHEUS LABORATORIES INC.
Reel/Frame 025556/0182 →
Assignment of Assignor's Interest Dec 19, 2012
From: PROMETHEUS LABORATORIES INC.
To: NESTEC S.A.
Reel/Frame 029504/0740 →
Assignment of Assignor's Interest Apr 18, 2017
From: NESTEC S.A.
To: DIATECH HOLDINGS, INC.
Reel/Frame 042045/0220 →
Change of Name Jul 5, 2017
From: DIATECH HOLDINGS, INC.
To: PIERIAN HOLDINGS, INC.
Reel/Frame 043086/0831 →
Merger Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →
Corrective Assignment to Correct the English Translation to Show the Full and Correct New Name in Section 51. Previously Recorded at Reel: 049391 Frame: 0756. Assignor(S) Hereby Confirms the Merger. Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
Corrective Assignment to Correct the Patent Number 16062921 Previously Recorded on Reel 049391 Frame 0756. Assignor(S) Hereby Confirms the Patent Number Should Have Been 16062912. Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
Corrective Assignment to Correct the Patent Number 16062921 Previously Recorded on Reel 049391 Frame 0756. Assignor(S) Hereby Confirms the Patent Number Should Have Been 16062912. Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →